AIRS, CG and CARS have been added to the Zacks Rank #5 (Strong Sell) List on April 14, 2025.
AIRS, CCB and CARS have been added to the Zacks Rank #5 (Strong Sell) List on April 2, 2025.
AIRS, EGBN and FFWM have been added to the Zacks Rank #5 (Strong Sell) List on March 26, 2025.
AVNS, AIRS and AMPH have been added to the Zacks Rank #5 (Strong Sell) List on March 24, 2025.
AirSculpt Technologies, Inc. (NASDAQ:AIRS ) Q4 2024 Earnings Conference Call March 14, 2025 8:30 AM ET Company Participants Allison Malkin - IR, ICR Yogi Jashnani - CEO Dennis Dean - CFO Conference Call Participants Joshua Raskin - Nephron Research Korinne Wolfmeyer - Piper Sandler Sam Eiber - BTIG Operator Greetings. Welcome to the AirSculpt Technologies Inc. Fourth Quarter 2024 Earnings Call.
AirSculpt Technologies, Inc. (AIRS) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of $0.02. This compares to earnings of $0.01 per share a year ago.
ASX, AIRS and BLKB have been added to the Zacks Rank #5 (Strong Sell) List on March 13, 2025.
ATS, AIRS and DIN have been added to the Zacks Rank #5 (Strong Sell) List on March 10, 2025.
AIRS, AROC and CAL have been added to the Zacks Rank #5 (Strong Sell) List on January 8, 2024.
AirSculpt Technologies, Inc. (NASDAQ:AIRS ) Q3 2024 Earnings Conference Call November 8, 2024 8:00 AM ET Company Participants Allison Malkin – ICR Dennis Dean – Interim Chief Executive Officer and Chief Financial Officer Conference Call Participants Joshua Raskin – Nephron Research LLC Korinne Wolfmeyer – Piper Sandler Operator Greetings, and welcome to AirSculpt Technologies, Inc. Third Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode.
Although the revenue and EPS for AirSculpt Technologies (AIRS) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
AirSculpt Technologies, Inc. (AIRS) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of $0.04. This compares to earnings of $0.05 per share a year ago.